Orient Bio Inc. has announced a private placement of 12th series unregistered and unsecured bonds with warrants due May 16, 2021, to raise gross proceeds of KRW 30,000 million (USD 26.44 million). The bonds yield to maturity will be 3% and exercise price will be KRW 1,205 (USD 1.06) per share and exercise ratio will be 100%. The company intends to use the proceeds for operations.